NCT03328780 is a clinical trial of Hemocue and Rad-67 measurement in Anemia, sponsored by Theusinger Oliver M..

Who is sponsoring NCT03328780?

NCT03328780 is sponsored by Theusinger Oliver M..

What drugs are being tested in NCT03328780?

Interventions in NCT03328780: Hemocue and Rad-67 measurement.

Is NCT03328780 still recruiting?

NCT03328780 is currently completed. Last updated 23 February 2018.

Last reviewed 2018-02-23 · How we verify

NCT03328780

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Anemia in Orthopedic Surgery - Determination of Hb

Completed Last updated 23 February 2018

What this trial tests

trial testing Hemocue and Rad-67 measurement in Anemia in 300 participants. Completed in 21 February 2018.

Timeline

18 December 2017

Primary endpoint
21 February 2018

21 February 2018

Quick facts

Lead sponsor	Theusinger Oliver M.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	300
Start date	18 December 2017
Primary completion	21 February 2018
Estimated completion	21 February 2018
Sites	1 location across Switzerland

Drugs / interventions tested

Hemocue and Rad-67 measurement

Conditions studied

Anemia — all drugs for Anemia →

Sponsor

Theusinger Oliver M.

Who can join

Adults 18 to 99, any sex, with Anemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Anemia prevalence in orthopedic surgery is up to 30 %. Identifying those patients prior to surgery and treating them would be ideal. Different ways of determining hemoglobin Levels are available. In this study classical laboratory determination, determination with HemoCue® and Rad-67™ will be performed to compare precision of those three methods as well as their correlation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Anemia

Currently open trials in the same condition.

NCT07422480 — A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myel · Phase 3 · recruiting
NCT06968936 — Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy · NA · recruiting
NCT07328191 — Quality of Life-Guided Transfusion in Refractory MDS or AML · NA · recruiting
NCT07315295 — Maximizing the Benefits of Iron in Ready-to-Use Therapeutic Foods for Malnourished Children in Kenya · NA · recruiting
NCT07400796 — Assessing Health System Readiness for Scaling Antenatal MMS in Cambodia · recruiting

Other Theusinger Oliver M. trials

Trials by the same sponsor.

NCT03346382 — Emergency Medical Services and Epilepsy in Switzerland · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03328780 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Theusinger Oliver M.
Last refreshed: 23 February 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03328780.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing